CASE STUDY
2025
OVERVIEW
Case StUDYPerigon Pharmacy has enhanced its Medesto Patient Engagement Platform with a new Enhanced Services Program module tailored for high-need specialty therapies.
A pilot program was initiated to support patients prescribed a newly launched specialty therapy addressing a chronic condition.
OBJECTIVES
Real-Time Data
Collect and deliver unique, real-world patient data to inform manufacturers about therapy usage trends and patient perspectives.
Adherence
Improve patient adherence and persistence through targeted engagement and educational touchpoints.
Solutions
Proactively identify barriers to adherence and create pharmacist-driven solutions.
Clinical Support
Enhance the patient journey by providing additional layers of clinical supportPATIENT POPULATION
• 217 new patients with new referrals for the month of March 2025
• Patients are very willing to engage and share information with the pharmacy
• Engagement far exceeded the expected level
LEARNINGS
20% - 30% ------------------------> 53%
INITIAL ASSESSMENT-SETTING THE BASELINE
DATA FINDINGS
How long have you been diagnosed with your condition?
MARKET INSIGHT - SAMPLE PROGRAM
How many patients receive samples from their provider?
MARKET INSIGHT - OTHER FACTORS
How many patients are also taking OTC medication in combination with their therapy?
ARE PATIENTS RESPONDING TO THERAPY?
Rate of Quality of Life (0 to 10) 10 being severe impact
DID WE IMPACT PERSISTENCY?
